These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32747793)

  • 1. Metabolic conditioning of CD8
    Klein Geltink RI; Edwards-Hicks J; Apostolova P; O'Sullivan D; Sanin DE; Patterson AE; Puleston DJ; Ligthart NAM; Buescher JM; Grzes KM; Kabat AM; Stanczak M; Curtis JD; Hässler F; Uhl FM; Fabri M; Zeiser R; Pearce EJ; Pearce EL
    Nat Metab; 2020 Aug; 2(8):703-716. PubMed ID: 32747793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and functional attributes of lentivirus-modified CD19-specific human CD8+ central memory T cells manufactured at clinical scale.
    Wang X; Naranjo A; Brown CE; Bautista C; Wong CW; Chang WC; Aguilar B; Ostberg JR; Riddell SR; Forman SJ; Jensen MC
    J Immunother; 2012; 35(9):689-701. PubMed ID: 23090078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8
    Ma R; Ji T; Zhang H; Dong W; Chen X; Xu P; Chen D; Liang X; Yin X; Liu Y; Ma J; Tang K; Zhang Y; Peng Y; Lu J; Zhang Y; Qin X; Cao X; Wan Y; Huang B
    Nat Cell Biol; 2018 Jan; 20(1):21-27. PubMed ID: 29230018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Sprouty 1 and 2 enhances survival of effector CD8
    Shehata HM; Khan S; Chen E; Fields PE; Flavell RA; Sanjabi S
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8939-E8947. PubMed ID: 30126987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.
    Hervas-Stubbs S; Mancheño U; Riezu-Boj JI; Larraga A; Ochoa MC; Alignani D; Alfaro C; Morales-Kastresana A; Gonzalez I; Larrea E; Pircher H; Le Bon A; Lopez-Picazo JM; Martín-Algarra S; Prieto J; Melero I
    J Immunol; 2012 Oct; 189(7):3299-310. PubMed ID: 22925929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inosine is an alternative carbon source for CD8
    Wang T; Gnanaprakasam JNR; Chen X; Kang S; Xu X; Sun H; Liu L; Rodgers H; Miller E; Cassel TA; Sun Q; Vicente-Muñoz S; Warmoes MO; Lin P; Piedra-Quintero ZL; Guerau-de-Arellano M; Cassady KA; Zheng SG; Yang J; Lane AN; Song X; Fan TW; Wang R
    Nat Metab; 2020 Jul; 2(7):635-647. PubMed ID: 32694789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
    Hu HM; Winter H; Urba WJ; Fox BA
    J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice.
    Hsu FT; Chen TC; Chuang HY; Chang YF; Hwang JJ
    Oncotarget; 2015 Dec; 6(42):44134-50. PubMed ID: 26683520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.
    Chandran SS; Paria BC; Srivastava AK; Rothermel LD; Stephens DJ; Kammula US
    Cancer Res; 2015 Aug; 75(16):3216-26. PubMed ID: 26100671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development.
    O'Sullivan D; van der Windt GJ; Huang SC; Curtis JD; Chang CH; Buck MD; Qiu J; Smith AM; Lam WY; DiPlato LM; Hsu FF; Birnbaum MJ; Pearce EJ; Pearce EL
    Immunity; 2014 Jul; 41(1):75-88. PubMed ID: 25001241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.
    Lynch A; Hawk W; Nylen E; Ober S; Autin P; Barber A
    Immunology; 2017 Nov; 152(3):472-483. PubMed ID: 28670716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High initial frequency of TCR-transgenic CD8 T cells alters inflammation and pathogen clearance without affecting memory T cell function.
    Wirth TC; Pham NL; Harty JT; Badovinac VP
    Mol Immunol; 2009 Nov; 47(1):71-8. PubMed ID: 19195704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
    Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
    J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of 6-phosphogluconate dehydrogenase generates CD8
    Daneshmandi S; Cassel T; Lin P; Higashi RM; Wulf GM; Boussiotis VA; Fan TW; Seth P
    Cell Rep; 2021 Mar; 34(10):108831. PubMed ID: 33691103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8
    Sanz-Ortega L; Portilla Y; Pérez-Yagüe S; Barber DF
    J Nanobiotechnology; 2019 Aug; 17(1):87. PubMed ID: 31387604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model.
    Contreras A; Beems MV; Tatar AJ; Sen S; Srinand P; Suresh M; Luther TK; Cho CS
    J Immunother Cancer; 2018 May; 6(1):41. PubMed ID: 29843822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reinforce the antitumor activity of CD8
    Nabe S; Yamada T; Suzuki J; Toriyama K; Yasuoka T; Kuwahara M; Shiraishi A; Takenaka K; Yasukawa M; Yamashita M
    Cancer Sci; 2018 Dec; 109(12):3737-3750. PubMed ID: 30302856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.
    Rodolfo M; Zilocchi C; Accornero P; Cappetti B; Arioli I; Colombo MP
    J Immunol; 1999 Aug; 163(4):1923-8. PubMed ID: 10438927
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Hu X; Majchrzak K; Liu X; Wyatt MM; Spooner CJ; Moisan J; Zou W; Carter LL; Paulos CM
    Cancer Res; 2018 Jul; 78(14):3888-3898. PubMed ID: 29769201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells.
    Chang J; Cho JH; Lee SW; Choi SY; Ha SJ; Sung YC
    J Immunol; 2004 Mar; 172(5):2818-26. PubMed ID: 14978082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.